• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. J-VAC RESERVOIR UNKNOWN PRODUCT; CATHETER AND TIP SUCTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. J-VAC RESERVOIR UNKNOWN PRODUCT; CATHETER AND TIP SUCTION Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Seroma (2069); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/01/2018
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Does the surgeon believe that ethicon products (blake drain, j-vac reservoir) involved caused and/or contributed to the post-operative complications (inflammatory seromas) (inflammation, seroma) described in the article? does the surgeon believe there was any deficiency with the ethicon products (blake drain, j-vac reservoir) used in this procedure? if yes, please provide patient demographics for the patients that experienced the post-operative complications (j-vac/blake: (b)(6) years old female patient (scmf group) who developed inflamamtory seroma).Were these cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.This report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.The single complaint was reported with multiple events.There are no additional details regarding the additional events.Note: events reported on mw# 2210968-2021-00710, mw# 2210968-2021-00711, mw# 2210968-2021-00713, mw# 2210968-2021-00714, mw# 2210968-2021-00719, mw# 2210968-2021-00720, mw# 2210968-2021-00722.Citation: ann plast surg 2018;81: 438¿440; doi: 10.1097/sap.0000000000001516.
 
Event Description
It was reported via journal article a reservoir was used: title: polyglycolic acid felt for prevention of frey syndrome after parotidectomy author(s): tetsushi aizawa, md, masahiro kuwabara, md, satoshi kubo, md, shimpo aoki, md, phd, ryuichi azuma, md, phd, and tomoharu kiyosawa, md, phd citation: ann plast surg 2018;81: 438¿440; doi: 10.1097/sap.0000000000001516.The purpose of this retrospective review was to evaluate the effectiveness of this polyglycolic acid (pga) felt as a barrier for preventing frey syndrome.From 2012 to 2017, 19 patients underwent superficial parotidectomy.Application of pga felt (n = 9) or sternocleidomastoid flap (scmf) transfer (n = 10) was performed to prevent frey syndrome.In both groups, a suction drain (j-vac/blake 15f; johnson & johnson k.K., tokyo, japan) was placed under the skin flap.Neither frey syndrome nor other major complications occurred in either group.Two patients from each group developed an inflammatory seroma that was successfully treated with a small incision for open drainage whom included (b)(6) years old female (pga group) patient, (b)(6) years old male patient (pga grou), (b)(6) years old male patient (scmf group) and (b)(6) years old female patient (scmf group).In previous studies of adm, papadogeorgakis et al19 reported that the incidence of seroma was 16%, and sinha et al21 reported an incidence of 25%, which were similar to our results.Use of pga felt successfully prevented frey syndrome, while being technically simpler and more rapid compared with scmf transfer.
 
Manufacturer Narrative
Product complaint # (b)(4).Date sent to the fda: (b)(6) 2021.Corrected information: b1, b2, d3, h1, h6- additional information was received that there are no issues with this device in the patient event.Therefore, this medwatch report will be voided.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
J-VAC RESERVOIR UNKNOWN PRODUCT
Type of Device
CATHETER AND TIP SUCTION
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08876
MDR Report Key11234010
MDR Text Key229107857
Report Number2210968-2021-00721
Device Sequence Number1
Product Code JOL
Combination Product (y/n)N
PMA/PMN Number
CL II EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Type of Report Initial,Followup
Report Date 01/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/04/2021
Initial Date FDA Received01/26/2021
Supplement Dates Manufacturer Received04/12/2021
Supplement Dates FDA Received04/28/2021
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age61 YR
-
-